Application Information

This drug has been submitted to the FDA under the reference 077833/001.

Names and composition

"NADOLOL AND BENDROFLUMETHIAZIDE" is the commercial name of a drug composed of BENDROFLUMETHIAZIDE and NADOLOL.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
077833/001 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 40MG
077833/002 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 80MG
078688/001 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 40MG
078688/002 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 80MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
018647/001 CORZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 40MG
018647/002 CORZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 80MG
077833/001 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 40MG
077833/002 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 80MG
078688/001 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 40MG
078688/002 NADOLOL AND BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE; NADOLOL TABLET/ORAL 5MG and 80MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved